Patient Reported Outcomes and Patient Education in Cellular Therapy Patients
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Brentuximab Vedotin in Adults With CD30-positive Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Phase I Safety and Pharmacokinetic Study of Gamitrinib Administered Intravenously to Patients With Advanced Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Telerehabilitation and Lymphoma Patients
- Status
- COMPLETED
- Phase
- NA
Dose Escalation and Expansion Study of CM313 in Subjects With Relapsed or Refractory Multiple Myeloma and Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1
Avatrombopag for the Primary Prevention of Thrombocytopenia Induced by Cytarabine-based Chemotherapy in Patients With Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCT
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
The Capability of Haemato-oncology Patients to Generate Antibodies Against COVID-19
- Status
- UNKNOWN
- Phase
- N/A
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid in Combination With Polatuzumab (ViPOR-P) in Relapsed/Refractory B-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
Pilot Study of an NTproBNP Guided Strategy of Cardioprotection
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Impact of a Sensory Rehabilitation Program on Olfactory-gustatory Alterations in Patients Treated With Chemotherapy for Haematological Cancer
- Status
- TERMINATED
- Phase
- NA
Integrative Neuromuscular Training in Adolescents and Children Treated for Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Evaluation of the Success of Prophylactic Enteral Nutrition in Therapeutic Intensification With Autograft of Autologous Hematopoietic Cells in Hematology
- Status
- COMPLETED
- Phase
- N/A
EFFECT OF A 16-SESSION QIGONG PROGRAM ON PHYSICAL AND MENTAL HEALTH IN PATIENTS WITH LYMPHOMA: A RANDOMIZED CONTROLLED TRIAL
- Status
- COMPLETED
- Phase
- NA
HM-178: Assessing Methods for Improvement in Methotrexate Toxicity Management and Detection of Central Nervous System Involvement of Aggressive Lymphoma
- Status
- SUSPENDED
- Phase
- PHASE2
A Study to Evaluate Glofitamab as Single Agent Administered After Pretreatment With Obinutuzumab in Chinese Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
National Longitudinal Cohort of Hematological Diseases
- Status
- RECRUITING
- Phase
- N/A
CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trial of CAR-T in the Treatment of Relapsed and Refractory Hematopoietic and Lymphoid Tissue Tumors in Children
- Status
- UNKNOWN
- Phase
- NA